9.5 Clinical Ophthalmology: Acute Red Eye, Glaucoma & Retinal Emergencies

The Acute Red Eye: Comprehensive Differential Diagnosis & Triage

The acute red eye represents one of the most common ophthalmic presentations in primary care and emergency departments. Clinical triage demands distinguishing self-limiting external superficial conditions from sight-threatening intraocular pathology requiring immediate specialist intervention.

Clinical Discriminators: Red Eye Comparison Framework

Conjunctivitis Subtypes: Bacterial, Viral & Allergic

• Bacterial Conjunctivitis: Commonly caused by Staphylococcus aureus, Streptococcus pneumoniae, and Haemophilus influenzae. Characterized by thick, copious purulent or mucopurulent discharge causing the eyelids to adhere together in the morning. Vision and pupillary responses are unaffected. Management consists of warm eyelid hygiene and broad-spectrum topical antibiotic therapy (e.g., chloramphenicol 0.5% drops, ciprofloxacin 0.3% drops, or erythromycin ointment) for 5 to 7 days. Hyperacute Bacterial Conjunctivitis: Hyperacute, abundant, explosive purulent discharge developing within 12 to 24 hours in a sexually active adult indicates Neisseria gonorrhoeae. N. gonorrhoeae can rapidly penetrate an intact corneal epithelium, producing severe stromal ulceration, corneal melting, and endophthalmitis within 24 to 48 hours. Treatment mandates immediate systemic therapy with intramuscular Ceftriaxone 1 g (plus oral Azithromycin 1 g for Chlamydia co-infection), frequent saline eye irrigation, and emergency ophthalmology admission.
• Viral Conjunctivitis (Epidemic Keratoconjunctivitis): Most frequently caused by Adenovirus (serotypes 8, 19, and 37). Highly contagious, spreading via hand-to-eye contact and contaminated ophthalmic equipment. Manifests with acute watery/serous discharge, conjunctival follicular hypertrophy on the lower palpebral conjunctiva, foreign body sensation, and tender preauricular lymphadenopathy. Treatment is strictly supportive (cold compresses, preservative-free artificial tears); strict hand hygiene and work/school exclusion are mandatory until discharge resolves (typically 10 to 14 days).
• Allergic Conjunctivitis: Type I IgE-mediated hypersensitivity reaction to airborne environmental allergens (pollen, animal dander, dust mites). Bilateral presentation with intense ocular pruritus (itching) as the hallmark feature, accompanied by watery or ropy stringy discharge, conjunctival edema (chemosis), and large cobblestone papillae on the superior tarsal conjunctiva. Treated with dual-action topical antihistamine / mast cell stabilizers (e.g., Olopatadine 0.1% or Ketotifen 0.025% twice daily).

Episcleritis vs. Scleritis: The Phenylephrine Test

• Episcleritis: Benign, self-limiting inflammation of the superficial episcleral vascular plexus situated beneath the conjunctiva but superficial to Tenon's capsule. Typically affects young to middle-aged adults, presenting with sectoral or diffuse bright red injection and mild discomfort or foreign body sensation without severe pain or visual loss. The 2.5% Phenylephrine Diagnostic Test: Instillation of one drop of 2.5% topical phenylephrine causes prompt, complete vasoconstriction and blanching of the superficial episcleral vessels within 5 to 10 minutes, demonstrating that the deeper scleral vascular network is not involved. Managed conservatively with cool compresses, artificial tears, or a short course of oral NSAIDs.
• Scleritis: Severe, destructive, chronic inflammation involving the deep episcleral and scleral vascular networks. Manifests with severe, deep, boring, unremitting ocular pain that radiates across the distribution of the ophthalmic and maxillary divisions of the trigeminal nerve (brow, temple, cheek, and jaw). The pain characteristically awakens the patient from sleep at night, is exacerbated by extraocular eye movements (due to rectus muscle traction on the inflamed sclera), and responds poorly to standard oral analgesics. Examination under natural ambient sunlight reveals a pathognomonic violaceous (deep bluish-red or purple) hue. Topical 2.5% phenylephrine fails to blanch the deep scleral vessels. Necrotizing scleritis can cause scleral thinning, uveal show and perforation. Scleromalacia perforans specifically denotes necrotizing scleritis without overt inflammation, usually painless. Approximately 50% of patients have an underlying systemic autoimmune connective tissue disease, most commonly Rheumatoid Arthritis (RA), followed by Granulomatosis with Polyangiitis (GPA / Wegener's), Relapsing Polychondritis, and Systemic Lupus Erythematosus (SLE). Topical eye drops alone are ineffective; management requires high-dose systemic oral NSAIDs (indomethacin), oral systemic corticosteroids (prednisone 1 mg/kg/day), or disease-modifying antirheumatic drugs (DMARDs / anti-TNF biologics) managed jointly with rheumatology.

Anterior Uveitis (Iritis / Iridocyclitis)

Anterior uveitis represents inflammation of the anterior portion of the uveal tract (the iris and anterior ciliary body). Over 50% of acute anterior uveitis cases demonstrate a strong genetic association with HLA-B27 positivity, including the seronegative spondyloarthropathies: Ankylosing Spondylitis, Reactive Arthritis, Psoriatic Arthritis, and Inflammatory Bowel Disease (Crohn's and Ulcerative Colitis). Non-HLA-B27 etiologies include sarcoidosis, juvenile idiopathic arthritis (JIA), Behçet's disease, syphilis, and tuberculosis.

• Clinical Presentation: Acute onset of deep, aching eye pain, blurred vision, and exquisite photophobia—both direct (light shone in the affected eye triggers pain) and consensual (light shone in the unaffected contralateral eye causes pupillary constriction and painful ciliary spasm in the affected eye).
• Physical Examination Findings:
  • Ciliary Flush: Violaceous, circumcorneal perilimbal injection radiating 1 to 3 mm outwards from the corneal limbus, caused by dilation of anterior ciliary vessels.
  • Pupillary Alterations: The pupil on the affected side is constricted (miotic), sluggish, and often irregular in shape due to the development of posterior synechiae (inflammatory adhesions anchoring the posterior pupillary margin of the iris to the anterior capsule of the crystalline lens).
  • Slit-Lamp Hallmarks: Slit-lamp biomicroscopy demonstrates cells and flare in the anterior chamber (circulating leukocytes and protein transudate reflecting breakdown of the blood-aqueous barrier, appearing like dust motes in a projector beam), keratic precipitates (KPs) (clusters of inflammatory cells deposited on the lower corneal endothelium), and in severe cases, a hypopyon (a visible horizontal fluid-fluid level of settled white blood cells layering in the inferior anterior chamber).
• Emergency Therapeutic Protocol:
  1. Topical Cycloplegics / Mydriatics: Instillation of long-acting cycloplegics such as Cyclopentolate 1% or Homatropine 2% (or Atropine 1%). Cycloplegia achieves two critical objectives: (a) paralyzes the ciliary muscle and pupillary sphincter, rapidly eliminating painful ciliary spasm; (b) maintains pupillary dilation (mydriasis), which pulls the iris pupillary margin away from the lens capsule, preventing new posterior synechiae formation and breaking early fragile synechiae.
  2. Topical Corticosteroids: Intensive topical Prednisolone acetate 1% drops (instilled hourly initially, then tapered) to suppress intraocular inflammation. Strict Prerequisite: Topical steroids must never be initiated before performing fluorescein staining to rigorously exclude herpes simplex dendritic keratitis, as steroids in epithelial HSV infection trigger disastrous geographic corneal ulceration and perforation.

Corneal Abrasions & Infectious Keratitis

• Corneal Abrasion: Traumatic mechanical disruption of the corneal epithelial layer. Patients present with sudden, excruciating foreign body sensation, lacrimation, severe blepharospasm, and photophobia. Instillation of topical fluorescein examined with a cobalt blue slit-lamp filter demonstrates vivid bright green fluorescence over the denuded epithelial basement membrane. Management incorporates topical broad-spectrum antibiotic prophylaxis (erythromycin or polymyxin B/trimethoprim) and oral analgesia. The Contact Lens Rule: Corneal abrasions in contact lens wearers must be treated with topical antipseudomonal fluoroquinolones (e.g., Ciprofloxacin 0.3% or Ofloxacin 0.3% drops) due to extreme risks of Pseudomonas aeruginosa superinfection. Two Absolute Contraindications: (1) Never patch an eye with a corneal abrasion (patching fosters a dark, warm, hypoxic environment that accelerates bacterial multiplication, especially Pseudomonas); (2) Never prescribe topical anesthetic drops (tetracaine, proparacaine) for outpatient home use; repeated self-administration destroys the corneal epithelial microvilli, eliminates protective blink reflexes, and induces toxic neurotrophic keratopathy leading to rapid, irreversible corneal stromal melting and perforation.
• Bacterial Keratitis (Corneal Ulcer): Bacterial invasion into the corneal stroma, manifesting as a discrete, focal, dense white or yellowish infiltrate/opacity on the cornea with an overlying epithelial defect and hypopyon. Over 70% of cases are related to overnight contact lens wear (Pseudomonas aeruginosa). This is an ophthalmic emergency requiring immediate urgent referral, diagnostic corneal scrapings for Gram stain and culture, and empirical round-the-clock intensive therapy with fortified topical antibiotics (e.g., alternating fortified Vancomycin 50 mg/mL and fortified Tobramycin 14 mg/mL, or high-dose topical Fluoroquinolones) administered every 30 to 60 minutes day and night.
• Herpes Simplex Virus (HSV-1) Keratitis: Reactivation of latent HSV-1 in the trigeminal ganglion. Hallmark physical finding is a dendritic corneal ulcer—a delicate, linear, arborizing/branching epithelial ulcer with characteristic terminal bulbous expansions that stain intensely with fluorescein dye. Corneal sensation tested with a fine cotton wisp is characteristically diminished or absent (corneal hypoesthesia). First-line therapy is topical Acyclovir 3% ophthalmic ointment (5 times daily for 10 to 14 days) or topical Ganciclovir 0.15% ophthalmic gel, or oral acyclovir. ABSOLUTE CONTRAINDICATION: Topical corticosteroids are strictly contraindicated in active epithelial HSV keratitis. Administering topical steroids abolishes host local cell-mediated immunity and fuels unchecked viral replication, rapidly transforming a focal dendritic ulcer into an expansive, invasive geographic (amoeboid) corneal ulcer resulting in massive stromal destruction, corneal scarring, and catastrophic perforation.

Glaucoma: Acute Angle-Closure vs. Chronic Open-Angle Glaucoma

Glaucoma encompasses a group of progressive optic neuropathies characterized by retinal ganglion cell death, neuroretinal rim thinning, and optic disc cupping, fundamentally categorized by anterior chamber angle configuration.

Acute Angle-Closure Glaucoma (AACG): Pathophysiology & Precipitants

AACG is an ophthalmic and surgical emergency resulting from sudden, complete mechanical occlusion of the trabecular meshwork by the peripheral iris, completely halting aqueous humor drainage from the anterior chamber into Schlemm's canal.

• Anatomical Predisposing Factors: Hyperopic (far-sighted) eyes with short axial length, shallow anterior chambers, and thick, anteriorly displaced crystalline lenses (prevalence increases with age and in East Asian and Inuit populations).
• The Pupillary Block Mechanism: In a mid-dilated pupillary position (approximately 4 to 6 mm), contact between the posterior iris pupillary margin and the anterior crystalline lens surface creates resistance to aqueous flow from the posterior chamber into the anterior chamber (pupillary block). Trapped aqueous accumulates in the posterior chamber, bowing the compliant peripheral iris forward (iris bombé). The bowed iris directly contacts and seals the iridocorneal drainage angle, occluding the trabecular meshwork.
• Precipitating Triggers: Transition from bright to dim ambient lighting (cinemas, night driving, emotional stress triggering sympathetic mydriasis); pharmacological agents with sympathomimetic or anticholinergic properties (atropine, cyclopentolate, ipratropium inhalers, over-the-counter decongestants with pseudoephedrine, first-generation antihistamines and tricyclic antidepressants). Topiramate causes a different, often bilateral effusion-mediated angle closure: stop the drug and obtain urgent ophthalmology treatment with aqueous suppressants and cycloplegia; avoid pilocarpine. LPI does not relieve this non-pupillary-block mechanism. The medical and LPI pathway below concerns primary pupillary-block angle closure.
• Clinical Presentation: Agonizing, hyperacute, unilateral ocular, frontal, and periorbital pain radiating along the ophthalmic (V1) distribution of the trigeminal nerve. Marked diminution of visual acuity accompanied by pathognomonic rainbow-colored halos around point lights (caused by diffraction of light through microcystic corneal epithelial edema). Autonomic activation routinely produces severe nausea, intractable vomiting, diaphoresis, and severe headache; patients frequently present to emergency departments and are misdiagnosed with acute gastroenteritis, migraine, or subarachnoid hemorrhage.
• Physical Examination Findings:
  • Marked ciliary injection and diffuse conjunctival hyperemia.
  • The cornea is dull, cloudy, and hazy with a 'steamy' ground-glass appearance.
  • The anterior chamber is shallow; oblique penlight illumination casts a prominent crescent shadow across the nasal iris.
  • The pupil is moderately dilated (4 to 6 mm), vertically oval, and fixed/non-reactive to direct and consensual light (due to ischemic paralysis of the pupillary sphincter).
  • The globe feels 'stony hard' and non-compressible on gentle digital ballottement through closed upper eyelids.
  • Tonometry: Intraocular pressure (IOP) is precipitously elevated, typically ranging from 40 to 80 mmHg (normal resting IOP: 10 to 21 mmHg).

Stepwise Emergency Medical Management of AACG

Emergency medical management must be instituted immediately to suppress aqueous humor production, induce vitreous dehydration, and reverse pupillary block before permanent ischemic optic nerve atrophy and retinal ganglion cell necrosis occur:

1. Systemic Carbonic Anhydrase Inhibitor: Intravenous Acetazolamide 500 mg bolus (followed by 250 mg PO three times daily). Carbonic anhydrase inhibition rapidly extinguishes bicarbonate production in the ciliary body epithelium, reducing aqueous humor secretion by > 50% within 30 minutes.
2. Topical Beta-Adrenergic Antagonist: Timolol 0.5% drops (1 drop instilled immediately). Competitively blocks ciliary process beta-2 receptors, decreasing aqueous humor formation.
3. Topical Alpha-2 Adrenergic Agonist: Apraclonidine 1% drops (1 drop instilled immediately). Suppresses aqueous production and stimulates uveoscleral outflow.
4. Topical Parasympathomimetic (Miotic Agent): Pilocarpine 2% drops. Stimulates muscarinic receptors on the pupillary sphincter muscle, inducing pupillary constriction (miosis). Sphincter contraction pulls the root of the peripheral iris tautly away from the trabecular meshwork, physically unblocking the iridocorneal angle. Crucial Pharmacological Timing: Pilocarpine is ineffective at IOPs > 40 to 50 mmHg because severe intraocular pressure induces focal ischemia of the pupillary sphincter, paralyzing its contractility. Pilocarpine should be initiated 30 to 60 minutes after acetazolamide and timolol have begun lowering IOP into a responsive physiological range (1 drop every 15 minutes for 2 doses, then every 6 hours).
5. Intravenous Hyperosmotic Therapy: Intravenous Mannitol 20% (1.0 to 2.0 g/kg infused over 30 to 45 minutes) is administered if IOP remains refractory (> 50 mmHg) after initial medical therapy. Mannitol rapidly increases serum intravascular osmolarity, drawing water out of the vitreous body into the retinal and choroidal circulation, reducing vitreous volume and pulling the crystalline lens-iris diaphragm posteriorly.

Definitive Intervention: Bilateral Laser Peripheral Iridotomy (LPI)

Once corneal edema clears and the IOP is brought under medical control, the definitive curative treatment is Bilateral Laser Peripheral Iridotomy (LPI) using an Nd:YAG laser. LPI creates a microscopic full-thickness aperture in the superior peripheral iris (hidden beneath the upper eyelid). This hole establishes a direct anatomical bypass channel, allowing aqueous humor to flow unobstructed from the posterior chamber directly into the anterior chamber, permanently equalizing trans-iris pressures and abolishing pupillary block.

MANDATORY BILATERAL PROCEDURE: The contralateral, unaffected eye MUST undergo prophylactic laser peripheral iridotomy during the same clinical encounter. The predisposing narrow-angle anatomical architecture is universally bilateral; up to 50% of untreated contralateral eyes will develop acute angle closure within 5 years.

Chronic Open-Angle Glaucoma (COAG / POAG)

Chronic open-angle glaucoma is a chronic, progressive, bilateral optic neuropathy characterized by acquired loss of optic nerve axons and thinning of the neuroretinal rim in the presence of an anatomically open anterior chamber angle.

• Pathophysiology: Insidious, progressive microscopic degenerative resistance to aqueous humor outflow within the trabecular meshwork and cribriform plates, leading to chronic elevation of IOP (though 30% of cases exhibit normal IOP, termed normal-tension glaucoma).
• Clinical Presentation: Asymptomatic in early and intermediate stages ("the silent thief of sight"). Patients experience no pain, redness, or acute vision loss. Gradual, insidious constriction of the visual field begins in the mid-periphery (arcuate scotomas, nasal stepping), slowly advancing over years to constricted 'tunnel vision'. Central visual acuity and color perception remain preserved until end-stage optic atrophy.
• Fundoscopic Hallmarks:
  • Enlarged Cup-to-Disc Ratio (CDR > 0.5): Progressive death of retinal ganglion cells enlarges the central optic cup relative to the overall optic disc diameter.
  • Asymmetric Cupping: A CDR difference >= 0.2 between the two eyes strongly indicates glaucomatous neuropathy.
  • Violation of the ISNT Rule: In a healthy optic nerve head, neuroretinal rim thickness follows the ISNT hierarchy: Inferior >= Superior >= Nasal >= Temporal. Glaucomatous damage selectively targets the inferior and superior poles first, violating this relationship.
  • Disc hemorrhages (Drance hemorrhages) and focal rim notching.
• First-Line Pharmacological Therapy: Topical Prostaglandin Analogues (PGAs)—Latanoprost 0.005%, Bimatoprost, or Travoprost—administered as a single drop at bedtime. PGAs bind to FP prostanoid receptors in the ciliary muscle, remodeling extracellular matrix and dramatically increasing uveoscleral unconventional aqueous outflow (reducing IOP by 25% to 35%). Highly favored due to once-daily dosing and absence of systemic cardiopulmonary side effects. Patient Counseling Points: Irreversible darkening/hyperpigmentation of the iris (especially in hazel/green eyes), hypertrichosis (lengthening, thickening, and darkening of eyelashes), and deepening of the superior eyelid sulcus (prostaglandin-associated periorbitopathy).
• Second-Line / Adjunctive Options: Topical beta-blockers (Timolol 0.5% bid; contraindicated in bronchial asthma, severe COPD, bradycardia, or 2nd/3rd degree heart block); Topical Alpha-2 agonists (Brimonidine 0.2% tid); Topical Carbonic Anhydrase Inhibitors (Dorzolamide 2% tid). Procedural escalation includes Selective Laser Trabeculoplasty (SLT) or surgical Trabeculectomy (creating a guarded filtering fistula to the subconjunctival space).

Acute Painless Vision Loss: Vascular Occlusions & Vitreoretinal Emergencies

Sudden, painless loss of vision in an adult represents a vascular, retinal, or central neurological catastrophe requiring rapid diagnostic differentiation.

Central Retinal Artery Occlusion (CRAO): An Acute Eye Stroke

CRAO represents an acute, catastrophic ischemic infarction of the inner two-thirds of the retina supplied by the central retinal artery (the first branch of the internal carotid-derived ophthalmic artery).

• Etiology & Mechanism: Embolic occlusion (75% to 80%) originating from ulcerated ipsilateral carotid atheroma, cardiac mural thrombus (atrial fibrillation), or calcific valvular vegetations. The remaining cases are thrombotic or arteritic (complicating Giant Cell Arteritis / Temporal Arteritis).
• Clinical Presentation: Sudden, painless, profound, unheralded loss of monocular vision (often reduced to light perception or counting fingers) occurring over seconds.
• Physical Examination Findings:
  • Relative Afferent Pupillary Defect (RAPD / Marcus Gunn Pupil): The swinging flashlight test reveals paradoxical pupillary dilation when light is moved from the healthy eye to the affected eye, confirming severe afferent pathway disruption.
  • Fundoscopic Appearance: Diffuse, ground-glass, opaque, milky-white pallor and edema of the retina (resulting from ischemic cellular swelling and loss of retinal transparency in the nerve fiber layer). Contrasting sharply against this ischemic white backdrop is the pathognomonic 'Cherry-Red Spot' at the fovea centralis. Because the fovea is extremely thin and completely devoid of ganglion cells, the milky edema cannot develop there; the healthy underlying vascular choriocapillaris shines through the thin fovea as an intense red circular dot.
  • Fragmentation and segmentation of the blood column within retinal arterioles, termed 'boxcarring' or 'cattle-trucking'.
• Emergency Management: CRAO is an acute retinal ischemic stroke. Immediately transfer the patient to a stroke-capable emergency service, with urgent ophthalmology and stroke-team assessment. Record the exact time of onset or last-known-well; there is no established 90-minute human treatment cutoff.
  1. Activate the Eye-Stroke Pathway: Confirm the ocular diagnosis promptly while assessing neurological signs and eligibility for any acute specialist intervention. Do not delay transfer for office-based tests or procedures.
  2. Avoid Unsupported Salvage Manoeuvres: Ocular massage, anterior chamber paracentesis, routine IOP-lowering treatment solely for CRAO, carbogen, nitrates and paper-bag rebreathing have no established visual benefit and must not delay stroke care.
  3. Reperfusion Decisions: Specialist teams consider the presentation, bleeding risk, current evidence and local protocol. Routine IV thrombolysis has not demonstrated benefit in the recent randomized THEIA and TenCRAOS trials; do not present it as proven treatment.
  4. Urgent Cause and Prevention Workup: Brain and head/neck vascular imaging, ECG/rhythm monitoring and cardiac investigations guide embolic-source identification and secondary prevention.
  5. Assess for Giant Cell Arteritis: In patients aged 50 or older, obtain ESR, CRP and a blood count and assess arteritic symptoms. Strong suspicion requires immediate corticosteroids without awaiting confirmation; visual ischemia may warrant IV methylprednisolone 500 to 1,000 mg daily for 3 days.

Central Retinal Vein Occlusion (CRVO): The 'Blood & Thunder' Fundus

CRVO results from thrombotic occlusion of the central retinal vein at or near the lamina cribrosa of the optic nerve, creating intense venous stasis, intraluminal hypertension, and diffuse capillary extravasation.

• Predisposing Risk Factors: Advanced age, systemic arterial hypertension, diabetes mellitus, hyperlipidemia, open-angle glaucoma, hyperviscosity syndromes (polycythemia vera, Waldenström macroglobulinemia), and thrombophilias (antiphospholipid syndrome, factor V Leiden).
• Clinical Presentation: Acute to subacute, painless, mild to severe monocular blurring or visual reduction, often noticed upon awakening in the morning.
• Fundoscopic Appearance: The classic 'Blood and Thunder' fundus:
  • Massive, widespread, superficial flame-shaped intraretinal hemorrhages and deep blot hemorrhages distributed across all four quadrants of the retina.
  • Extreme venous engorgement, tortuosity, and dilation.
  • Marked optic disc edema with indistinct, hyperemic disc margins.
  • Scattered cotton-wool spots (ischemic axoplasmic flow stasis).
• Major Complications & Management: Retinal ischemia stimulates massive intraocular release of Vascular Endothelial Growth Factor (VEGF), causing severe macular edema (the leading cause of vision loss) and neovascular glaucoma (traditionally called '90-day glaucoma', where fibrovascular membranes occlude the trabecular meshwork ~3 months post-thrombosis). Management focuses on monthly intravitreal injections of Anti-VEGF agents (Aflibercept, Ranibizumab) or intravitreal dexamethasone implants to resolve macular edema, alongside Panretinal Photocoagulation (PRP) if retinal neovascularization arises.

Retinal Detachment (RD): Tears, Floaters & The Dark Curtain

Retinal detachment is the pathological separation of the neurosensory retina from the underlying retinal pigment epithelium (RPE), extinguishing the metabolic and oxygen supply provided by the choroid.

• Pathophysiological Classifications:
  1. Rhegmatogenous RD (Most Common): A full-thickness tear or break in the sensory retina (rhegma = tear) allows liquefied vitreous fluid to dissect into the potential subretinal space. Classically precipitated by acute posterior vitreous detachment (PVD) in myopic (near-sighted) eyes, following cataract extraction, or after ocular blunt trauma.
  2. Tractional RD: Fibrovascular contractile membranes on the retinal surface mechanically pull the neurosensory retina away from the RPE. Classically seen in proliferative diabetic retinopathy, retinopathy of prematurity, or sickle cell retinopathy.
  3. Exudative / Serous RD: Subretinal fluid accumulation without a retinal break, caused by hydrostatic or inflammatory fluid transudation (choroidal melanoma, severe malignant hypertension, Vogt-Koyanagi-Harada syndrome).
• The Classic Clinical Triad:
  1. Photopsia: Brief, recurring flashes of light in the peripheral visual field, caused by physical vitreoretinal traction mechanically stimulating retinal photoreceptors.
  2. Sudden Shower of Floaters: Multiple dark specks, cobwebs, or a ring-like floater (Weiss ring) floating across vision, produced by red blood cells or condensed vitreous fibers.
  3. Progressive 'Dark Curtain' or 'Shadow': A dense, dark, painless visual field defect that starts in the far periphery and steadily advances toward the center over hours or days, corresponding geometrically to the expanding detached quadrant.
• Physical & Slit-Lamp Findings:
  • Shafer's Sign ('Tobacco Dust'): The presence of tiny, brownish-pigmented clumps of retinal pigment epithelial cells suspended in the anterior vitreous behind the crystalline lens. Pathognomonic for a full-thickness retinal tear.
  • Ophthalmoscopy: The detached neurosensory retina appears as an elevated, corrugated, translucent, greyish-white billowing veil with folded contours that undulates and ripples with eye motion. Retinal blood vessels appear dark and tortuous as they drape over the billowing folds.
• Surgical Management: Emergency ophthalmology referral. The patient is placed on bed rest with the head positioned so gravity assists in keeping the tear dependent. Rhegmatogenous detachment requires surgical repair: pneumatic retinopexy (intravitreal gas bubble injection), scleral buckling (encircling silicone band indenting the sclera), or pars plana vitrectomy (PPV) with endolaser barrier photocoagulation and gas/silicone oil tamponade. The Macula Status Emergency: A 'Macula-On' detachment (central acuity still 20/20) is an absolute, immediate surgical emergency requiring operative intervention within 24 hours to prevent the macula from detaching; once the macula detaches ('Macula-Off'), central visual recovery is significantly compromised.

Vitreous Hemorrhage

Vitreous hemorrhage is the extravasation of blood into the normally clear gel of the vitreous cavity. The leading etiology worldwide is Proliferative Diabetic Retinopathy (35% to 50%), where fragile, abnormal neovascular vessels rupture under vitreoretinal traction. Additional etiologies include retinal tears/detachment, retinal vein occlusion, and blunt trauma.

• Presentation: Sudden, painless onset of severe visual blurring, floaters, a red or dark haze, or complete visual blackout.
• Examination: Diminished or completely absent red reflex on distant direct ophthalmoscopy. Slit-lamp biomicroscopy reveals RBCs suspended in the vitreous cavity; the retina is partially or completely obscured from view.
• Management: Bedside B-scan ultrasonography must be performed urgently to evaluate whether an occult retinal tear or retinal detachment underlies the hemorrhage. Conservative care includes head elevation and retinal follow-up. Do not routinely stop medically indicated aspirin: ETDRS found no worsening of vitreous hemorrhage. Pars plana vitrectomy is considered for non-clearing hemorrhage, often after 1 to 3 months according to its cause, or urgently when retinal detachment is present.

Chronic Vision Loss & Systemic Retinopathies: Diabetic & Hypertensive Patterns

Systemic microvascular disease manifests directly within the retinal circulation, providing an accessible in vivo window into end-organ damage.

Diabetic Retinopathy: Staging & Pathophysiology

Diabetic retinopathy is a progressive microangiopathy driven by chronic hyperglycemia, aldose reductase pathway activation, sorbitol accumulation, oxidative stress, and pericyte apoptosis, resulting in microvascular breakdown and retinal non-perfusion.

• Non-Proliferative Diabetic Retinopathy (NPDR):
  • Mild NPDR: Microaneurysms only, without other retinopathy lesions. A microaneurysm is a focal capillary outpouching, often related to pericyte loss, appearing as a tiny, sharply circumscribed red dot.
  • Moderate NPDR: More than microaneurysms alone but less than severe NPDR, with lesions such as intraretinal dot-and-blot hemorrhages (deep hemorrhages in the inner nuclear and outer plexiform layers), hard exudates (discrete, yellow, waxy lipid deposits with sharp borders formed by chronic lipoprotein leakage from hyperpermeable capillaries), and cotton-wool spots (fluffy, greyish-white lesions with feathered edges representing localized microinfarctions of the retinal nerve fiber layer due to arteriolar occlusion, causing axoplasmic flow stasis).
  • Severe NPDR (The Validated 4-2-1 Rule): Patient exhibits ANY ONE of the following criteria without proliferative vessels: (1) Severe intraretinal hemorrhages and microaneurysms in all 4 quadrants; (2) Definite venous beading (segmental venous dilation resembling a string of sausages) in 2 or more quadrants; (3) Prominent Intraretinal Microvascular Abnormalities (IRMA—dilated, tortuous shunt vessels) in 1 or more quadrants.
  • Diabetic Macular Edema (DME): Retinal thickening caused by fluid leakage, which may involve or threaten the fovea centralis; hard exudates may accompany the edema but do not alone establish it. Can occur at any stage of NPDR or PDR and represents the single leading cause of moderate visual impairment in diabetic patients. Diagnosed and quantified with Optical Coherence Tomography (OCT).
• Proliferative Diabetic Retinopathy (PDR): Severe, sustained capillary non-perfusion creates extensive retinal tissue hypoxia, stimulating massive upregulation and secretion of Vascular Endothelial Growth Factor (VEGF) and basic fibroblast growth factor. Hypoxia drives pathological angiogenesis, characterized by Neovascularization of the Disc (NVD) (abnormal new vessels budding on or within 1 disc diameter of the optic disc) or Neovascularization Elsewhere (NVE) along major retinal vascular arcades. These aberrant neovascular vessels are fragile, porous, and lack pericytes and mature tight junctions, predisposing to recurrent vitreous hemorrhage, fibrovascular traction bands, and secondary tractional retinal detachment.
• Management Paradigms:
  • Strict systemic optimization: HbA1c < 7.0%, blood pressure < 130/80 mmHg, and lipid lowering.
  • Intravitreal Anti-VEGF Pharmacotherapy: First-line for center-involving diabetic macular edema and highly effective for PDR (Aflibercept, Ranibizumab, or Bevacizumab administered via serial monthly intravitreal injections).
  • Panretinal Photocoagulation (PRP): Application of 1,200 to 1,600 scatter laser burns across the ischemic peripheral retina. PRP reduces oxygen demand in the peripheral retina, decreasing hypoxic drive and VEGF production to promote neovascular regression. Persistent or recurrent activity may require further treatment.

Hypertensive Retinopathy: The Keith-Wagener-Barker Classification

Chronic arterial hypertension produces progressive morphological alterations in the retinal arterioles, categorized into four progressive grades:

• Grade 1 (Arteriolar Narrowing): Mild, generalized narrowing and attenuation of retinal arterioles, without the definite sclerosis and arteriovenous crossing changes of Grade 2.
• Grade 2 (Arteriovenous Nicking / Nipping): Advanced sclerosis thickens the common adventitial sheath where a retinal arteriole crosses over a retinal venule. The rigid, sclerotic arteriole mechanically compresses, indents, and deflects the crossing venule, producing Arteriovenous (AV) nicking / nipping (Gunn sign: tapering of the venule on either side of the crossing; Salus sign: S-shaped deflection of the crossing venule). Increasing wall opacity produces 'copper wiring', progressing to 'silver wiring' with advanced sclerosis.
• Grade 3 (Breakdown of Blood-Retinal Barrier): Marked acute microvascular injury. Features of Grade 2 plus: (1) Flame-shaped retinal hemorrhages (superficial intraretinal hemorrhages oriented horizontally within the retinal nerve fiber layer); (2) Cotton-wool spots (microinfarcts); (3) Macular Star: Hard lipid and proteinaceous exudates radiating symmetrically outward along Henle's fiber layer from the fovea, forming a distinct stellar pattern around the macula.
• Grade 4 (Malignant / Accelerated Hypertensive Retinopathy): All features of Grade 3 accompanied by Optic Disc Edema (Papilledema)—bilateral swelling of the optic nerve head with blurred disc margins, disc hyperemia, and loss of spontaneous venous pulsations. Grade 4 retinopathy defines Malignant (Accelerated) Hypertension and represents a critical hypertensive emergency.
• Emergency Management of Grade 4 Hypertensive Retinopathy: Immediate admission to an intensive care unit (ICU) for continuous intra-arterial blood pressure monitoring. Intravenous parenteral antihypertensive titration is initiated—predominantly intravenous Labetalol or intravenous Nicardipine. Hemodynamic Safety Rule: The Mean Arterial Pressure (MAP) must never be reduced by more than 20% to 25% over the first 1 to 2 hours (target blood pressure ~160/100 mmHg over 2 to 6 hours). Rapid, precipitous drops in systemic perfusion exceed the autoregulatory capacity of cerebral and retinal arterioles, precipitating catastrophic watershed cerebral infarction, bilateral anterior ischemic optic neuropathy, and permanent blindness.

Emergency Chemical Ocular Burns: Immediate Decontamination Protocol

Chemical burns of the eye represent one of the few true ophthalmic emergencies requiring instantaneous therapeutic intervention before any formal diagnostic workup or clinical history taking.

Pathophysiological Distinction: Alkali vs. Acid Agents

• Alkali Burns (Most Severe & Destructive):
  • Common Agents: Ammonia (NH3, found in commercial fertilizers, refrigerants, and glass cleaners; highest penetration rate), Sodium hydroxide (NaOH / Lye, in drain openers and oven cleaners), Potassium hydroxide, Calcium hydroxide (lime / slaked lime, present in plaster, mortar, and wet cement).
  • Mechanism: Alkalis are lipophilic and trigger liquefactive necrosis. Hydroxyl ions (OH-) saponify fatty acids within cell membranes, causing rapid cytolysis. Concurrently, alkaline denaturation of stromal glycosaminoglycans and collagen fibers causes rapid corneal softening, stromal edema, and deep penetration into the anterior chamber within minutes. Destruction of the trabecular meshwork induces acute glaucoma; penetration into the ciliary body and lens produces cataracts and hypotony.
• Acid Burns:
  • Common Agents: Sulfuric acid (H2SO4, car batteries), Hydrochloric acid (muriatic acid, pool cleaners), Nitric acid. (Exception: Hydrofluoric acid behaves like an alkali due to deep fluoride ion penetration).
  • Mechanism: Acids trigger coagulative necrosis. Hydrogen ions (H+) denature and precipitate corneal stromal proteins, forming an insoluble, opaque superficial protein coagulum barrier. This protein barrier buffers the acid and physically retards deeper penetration into the stroma and intraocular structures.
• The Hallmark Prognostic Discriminator: Limbal Blanching: The corneal limbus (the 1 mm junction between cornea and sclera) contains the Vogt palisades, which house the limbal epithelial stem cells responsible for continuous renewal and regeneration of the corneal epithelium. Severe chemical injury destroys the limbal microvasculature, producing limbal ischemia / blanching (an ominous, chalky 'porcelain white' appearance of the limbal rim). Extensive limbal stem cell deficiency (> 50% limbal involvement) prevents re-epithelialization, leading to persistent stromal ulceration, corneal melting, conjunctivalization of the cornea (pannus), and permanent corneal blindness.

The Standardized Emergency Management Protocol

Every second of delay accelerates irreversible intraocular destruction. Clinical management follows an immutable, prioritized sequence:

1. INSTANTANEOUS COPIOUS IRRIGATION (PRIORITY ZERO):
   • Irrigation must be instituted immediately at the scene of injury and continued instantly upon arrival in the emergency department BEFORE taking a history, before measuring visual acuity, and before formal physical examination.
   • Topical Anesthetic Instillation: Instill 1 to 2 drops of topical 0.5% proparacaine or 0.5% tetracaine immediately. Anesthesia abolishes agonizing pain and breaks severe blepharospasm, permitting effective, wide eyelid retraction.
   • Irrigating Fluid & Volume: Continuous irrigation with 1 to 2 liters per eye of sterile normal saline (0.9% NaCl), Ringer's lactate, or balanced salt solution. If commercial eye irrigation equipment (Morgan lens) is unavailable, connect standard intravenous infusion tubing to a 1,000 mL saline bag, holding the open tubing 2 to 3 cm above the eye and running the fluid wide open across the ocular surface.
2. Mechanical Debridement of Trapped Particulate Matter:
   • Both the upper and lower eyelids must be everted (including double eversion of the upper lid using a Desmarres lid retractor or cotton-tipped swab).
   • The superior and inferior conjunctival fornices must be systematically swept with a sterile, moistened cotton-tipped applicator to mechanically dislodge and evacuate all trapped particulate chemical debris (especially critical for solid lime or wet cement particles, which remain lodged in the fornices and continuously leach alkaline calcium hydroxide into the tear film for hours).
3. Objective Endpoint of Irrigation: The pH Normalization Rule:
   • Irrigation must continue continuously until the ocular surface pH is documented between 7.0 and 7.2 (normal ocular tear pH: 7.0 to 7.3).
   • The Measurement Protocol: Pause the irrigation stream and wait 5 to 10 minutes before testing the inferior conjunctival sac with broad-range pH indicator paper (litmus paper or urinalysis dipstick). Testing immediately after stopping irrigation tests the irrigating solution itself, providing a false-normal reading while residual chemical continues to leach from deep tissues. If pH remains alkaline (> 7.4) or acidic (< 7.0) after 10 minutes, irrigation must be resumed with an additional liter of fluid and re-tested until true neutral pH stability is achieved.
4. Post-Decontamination Medical Therapy:
   • Once physiological pH neutralization is confirmed, proceed with full examination, visual acuity measurement, and fluorescein staining.
   • Instill topical cycloplegics (Cyclopentolate 1%) to relieve ciliary spasm.
   • Topical broad-spectrum antibiotic ointment (e.g., erythromycin or ciprofloxacin).
   • High-dose topical corticosteroids (Prednisolone acetate 1% q1h for the first 7 to 10 days to suppress acute stromal inflammation; must be tapered after 10 days to prevent collagenase-mediated corneal melt).
   • Topical Sodium Ascorbate (Vitamin C 10%) drops and oral Vitamin C (1 to 2 g/day) to stimulate collagen synthesis and promote corneal wound healing.
   • Urgent in-person ophthalmology consultation for staging according to the Roper-Hall or Dua classification.

Worked Clinical Case: Acute Monocular Vision Loss in a Hypertensive Patient

A 69-year-old female with a 15-year history of arterial hypertension and non-insulin-treated type 2 diabetes presents to the urgent care eye clinic. She reports that 45 minutes prior, while eating breakfast, the vision in her left eye suddenly disappeared 'like a light switch being turned off.' She has zero eye pain, redness, discharge, or headache. On examination, visual acuity in the right eye is 20/25, but in the left eye is limited to counting fingers at 1 foot. Pupillary examination reveals a marked Relative Afferent Pupillary Defect (RAPD / Marcus Gunn pupil) in the left eye. The anterior segment is completely quiet with normal intraocular pressures bilaterally (15 mmHg OD, 14 mmHg OS).

1. Ophthalmoscopic Examination: Dilated fundoscopy of the left eye reveals diffuse milky-white edema and pallor of the sensory retina with marked narrowing of the retinal arterioles. At the center of the macula, a prominent, circumscribed, intense 'cherry-red spot' is visualized. Retinal veins demonstrate slow, fragmented blood columns.
2. Diagnostic Assessment: The acute, painless catastrophic vision loss, marked RAPD, and classic cherry-red spot amidst retinal pallor definitively confirm an acute Central Retinal Artery Occlusion (CRAO) of the left eye. The 45-minute onset makes immediate activation of the eye-stroke pathway essential; no fixed 90-minute human cutoff should be used to deny urgent assessment.
3. Immediate Emergency Interventions:
   • Emergency transfer to a stroke-capable service is arranged immediately, with ophthalmology and stroke-team notification. Onset time, visual acuity, pupils, neurological findings and medication history are documented without delaying transport.
   • Ocular massage, paper-bag rebreathing and routine acetazolamide solely for CRAO are omitted. Acute treatment decisions are made by the specialist team; the patient is not promised visual recovery from unproven thrombolysis.
   • ESR 14 mm/h and CRP 2.1 mg/L lower the probability of GCA but do not exclude it. Persistent clinical suspicion requires immediate corticosteroids and urgent confirmatory vascular imaging or temporal artery biopsy.
   • The stroke team is mobilized; emergent carotid Doppler ultrasound demonstrates an 85% ulcerated stenosis of the left internal carotid artery bulb, confirming the embolic source. The patient is admitted for systemic secondary stroke prevention and vascular surgical consultation for carotid endarterectomy.